ZVRA
ZEVRA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$10.45
+2.87%Forward multiples
Based on analyst estimates
- P/E forward
- 10.64x
- P/E 2026E
- 9.41x
- P/E 2027E
- 11.15x
- P/E 2028E
- 7.40x
- P/S forward
- 3.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- 10.88x
- PEG TTM
- 4.66x
- Price / book
- 2.85x
- Price / sales
- 4.56x
- Price / cash flow
- 18.58x
Enterprise value
- Enterprise value
- $400.6M
- EV / sales
- 2.94x
- EV / EBITDA
- 5.48x
- EV / EBIT
- 10.25x
- Market cap
- $620.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026